This morning, the Chancellor of the Exchequer George Osborne visited Great Ormond Street Hospital (GOSH) to announce a new £800 million boost to biomedical research through the National Institute for Health Research (NIHR). He was joined by the Secretary
Changes in the normal pattern of many genes involved in brain function could be the cause of intellectual disability in individuals with Down syndrome (DS.)
Following productive talks at Acas between the British Medical Association (BMA), NHS Employers and the Department of Health (DH), the proposed strike action on 1, 8 and 16 December has been temporarily suspended.
With the Give to GOSH appeal now in full swing, Dr. Peter Steer, CEO of Great Ormond Street Hospital (GOSH), provides a reminder of why we need support…
A new treatment that uses ‘molecular scissors’ to edit genes and create designer immune cells programmed to hunt out and kill drug resistant leukaemia has been used at Great Ormond Street Hospital (GOSH).
